An interventional study of Hyoscine Butylbromide 20Mg/1mL Injection and Saline Solution in Labor, sponsored by Saint Thomas Hospital, Panama. Completed at 1 site in Panama. Open to female participants. Per ClinicalTrials.gov, last updated 2019-12-06.
Sponsored by Saint Thomas Hospital, Panama · Not applicable, Interventional, and Treatment
To evaluate the duration of labour (active phase of labour) in nulliparous women with gestations between 37 and 41 6/7 weeks when 20 mg of Hyoscine butylbromide was applied intravenously and compared with similar patients that received a placebo.
Exclusion Criteria:
Nulliparous women with gestations at term receive 20 mg of Hyoscine butylbromide IV upon arrival in the Labor and Delivery Unit (4-5 cms).
Drug: Hyoscine Butylbromide 20Mg/1mL Injection
Nulliparous women with gestations at term receive Saline Solution IV upon arrival in the Labor and Delivery Unit (4-5 cms).
Drug: Saline Solution
Nulliparous women with gestations at term receive 20 mg of Hyoscine butylbromide upon arrival in the Labor and Delivery Unit (4-5 cms).
Nulliparous women with gestations at term receive 20 mg of saline solution upon arrival in the Labor and Delivery Unit (4-5 cms).
Duration of first stage of labor
Time measured from the moment the patient receive the allocated medication/placebo to complete dilation
Time frame: 24 hours
Rate of cervical dilation
Speed of cervical dilation (cms/hour) from the moment the patient receive the allocated medication/placebo to complete dilation
Time frame: 24 hours
Duration of labor
Time measured from the moment the patient receive the allocated medication/placebo to delivery
Time frame: 24 hours
Fetal and neonatal complications
Number of adverse events (fetal or neonatal)
Time frame: 72 hours
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Dec 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Saint Thomas Hospital, Panama